Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Thalidomide for Asymptomatic Multiple Myeloma
NCT00038233Phase 3Completed
- Sponsor
- University of Texas MD Anderson Cancer Center
- Start
- May 1999
- Primary completion
- Apr 2005
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of thalidomide in multiple myeloma (MM), sponsored by University of Texas MD Anderson Cancer Center. Started May 1999; status: completed.
02
Drugs
thalidomide
03
Conditions
multiple myeloma (MM)
Beyond the preview
Go deeper on NCT00038233.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00038233.